(Circulation. 1999;99:2255-2260.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Klinik und Poliklinik für Innere Medizin II, University of Regensburg, Regensburg, Germany (H.S., C.H., S.R.H., U.B., A.L., M.W.M., S.K., G.A.J.R.); Institut für Epidemiologie und Sozialmedizin, University of Münster, Münster, Germany (H.-W.H.); and GSF Forschungszentrum, Institut für Epidemiologie, Munich-Neuherberg (A.D., H.-W.H.), Germany.
Correspondence to Prof Dr H. Schunkert, Klinik und Poliklinik für Innere Medizin II, University of Regensburg, D-93042 Regensburg, Germany. e-mail heribert.schunkert{at}klinik.uni-regensburg.de
BackgroundCardiac growth and function may be modulated in part by trophic effects of neurohormones. Specifically, aldosterone has been shown to stimulate the growth of cardiac myocytes and the accumulation of cardiac extracellular matrix proteins. Moreover, a variant of the aldosterone synthase gene (a cytosine/thymidine exchange at position -344 in the transcriptional regulatory region) has been associated with enlargement and disturbed filling of the left ventricle (LV) in a small sample of young white adults. The aim of the present study was to reinvestigate the implications of aldosterone synthase -344C/T allele status for serum aldosterone levels, blood pressure, and LV structure and function in large population-based samples.
Methods and ResultsIndividuals who participated in the echocardiographic substudy of the third MONICA (MONitoring trends and determinants in CArdiovascular disease) survey (n=1445) or in the second follow-up of the first MONICA survey (n=562) were studied by standardized anthropometric, echocardiographic, and biochemical measurements as well as genotyping for aldosterone synthase -344C/T allele status. In both surveys, the distribution of sex, age, arterial blood pressure, and body mass index was homogeneous in the aldosterone synthase genotype groups. Echocardiographic LV wall thicknesses, dimensions, and mass indexes were not significantly associated with a specific aldosterone synthase genotype. Likewise, no association was detectable with echocardiographic measures of LV systolic or diastolic function. Data were consistent in both samples and not materially different in subgroups defined by age, sex, or intake of antihypertensive medication. Finally, no significant association was observed for aldosterone synthase allele status and serum aldosterone levels in the group of 562 individuals.
ConclusionsThe data are not in favor of a significant contribution of the C/T exchange at position -344 in the aldosterone synthase transcriptional regulatory region to the variability of serum aldosterone levels, blood pressure, or cardiac size or function as found in 2 white population-based samples.
Key Words: aldosterone genetics hypertrophy
This article has been cited by other articles:
![]() |
R. S. Vasan, N. L. Glazer, J. F. Felix, W. Lieb, P. S. Wild, S. B Felix, N. Watzinger, M. G. Larson, N. L. Smith, A. Dehghan, et al. Genetic Variants Associated With Cardiac Structure and Function: A Meta-analysis and Replication of Genome-wide Association Data JAMA, July 8, 2009; 302(2): 168 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Sookoian, T F Gianotti, and C J Pirola Role of the C-344T aldosterone synthase gene variant in left ventricular mass and left ventricular structure-related phenotypes Heart, July 1, 2008; 94(7): 903 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. H. Frey, W. Lieb, J. Erdmann, D. Savidou, G. Heusch, K. Leineweber, H. Jakob, H.-W. Hense, H. Lowel, N. H. Brockmeyer, et al. Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans Eur. Heart J., April 1, 2008; 29(7): 888 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Barr, S. M. MacKenzie, E. C. Friel, C. D. Holloway, D. M. Wilkinson, N. J.R. Brain, M. C. Ingram, R. Fraser, M. Brown, N. J. Samani, et al. Polymorphic Variation in the 11{beta}-Hydroxylase Gene Associates With Reduced 11-Hydroxylase Efficiency Hypertension, January 1, 2007; 49(1): 113 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
Wenxia Chai, Y. M Hoedemaekers, R. H. van Schaik, M. van Fessem, I. M Garrelds, J. J Saris, D. Dooijes, F. J ten Cate, M. M. Kofflard, and A. J. Danser Cardiac aldosterone in subjects with hypertrophic cardiomyopathy Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 225 - 230. [Abstract] [PDF] |
||||
![]() |
N. Makhanova, M. L.S. Sequeira-Lopez, R. A. Gomez, H.-S. Kim, and O. Smithies Disturbed Homeostasis in Sodium-Restricted Mice Heterozygous and Homozygous for Aldosterone Synthase Gene Disruption Hypertension, December 1, 2006; 48(6): 1151 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mayer, W. Lieb, A. Gotz, I. R. Konig, Z. Aherrahrou, A. Thiemig, S. Holmer, C. Hengstenberg, A. Doering, H. Loewel, et al. Association of the T8590C Polymorphism of CYP4A11 With Hypertension in the MONICA Augsburg Echocardiographic Substudy Hypertension, October 1, 2005; 46(4): 766 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases Physiol Rev, April 1, 2005; 85(2): 679 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. White and W. E. Rainey Polymorphisms in CYP11B Genes and 11-Hydroxylase Activity J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1252 - 1255. [Full Text] [PDF] |
||||
![]() |
B. Keavney, B. Mayosi, N. Gaukrodger, H. Imrie, M. Baker, R. Fraser, M. Ingram, H. Watkins, M. Farrall, E. Davies, et al. Genetic Variation at the Locus Encompassing 11-{beta} Hydroxylase and Aldosterone Synthase Accounts for Heritability in Cortisol Precursor (11-Deoxycortisol) Urinary Metabolite Excretion J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1072 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Vasan, J. C. Evans, E. J. Benjamin, D. Levy, M. G. Larson, J. Sundstrom, J. M. Murabito, F. Sam, W. S. Colucci, and P. W. F. Wilson Relations of Serum Aldosterone to Cardiac Structure: Gender-Related Differences in the Framingham Heart Study Hypertension, May 1, 2004; 43(5): 957 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stella, G. Bigatti, L. Tizzoni, C. Barlassina, C. Lanzani, G. Bianchi, and D. Cusi Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension J. Am. Coll. Cardiol., January 21, 2004; 43(2): 265 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. White Aldosterone: Direct Effects on and Production by the Heart J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2376 - 2383. [Full Text] [PDF] |
||||
![]() |
J. Nicod, D. Bruhin, L. Auer, B. Vogt, F. J. Frey, and P. Ferrari A Biallelic Gene Polymorphism of CYP11B2 Predicts Increased Aldosterone to Renin Ratio in Selected Hypertensive Patients J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2495 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Schunkert and J Erdmann Well kept secrets of the genome Eur. Heart J., March 2, 2003; 24(6): 501 - 503. [Full Text] [PDF] |
||||
![]() |
L. Swan, D.H. Birnie, S. Padmanabhan, G. Inglis, J.M.C. Connell, and W.S. Hillis The genetic determination of left ventricular mass in healthy adults Eur. Heart J., March 2, 2003; 24(6): 577 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Lim, T. M. Macdonald, C. Holloway, E. Friel, N. H. Anderson, E. Dow, R. T. Jung, E. Davies, R. Fraser, and J. M. C. Connell Variation at the Aldosterone Synthase (CYP11B2) Locus Contributes to Hypertension in Subjects with a Raised Aldosterone-to-Renin Ratio J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4398 - 4402. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sedlacek, M. Fischer, J. Erdmann, C. Hengstenberg, S. Holmer, S. Kurzinger, M. Muscholl, A. Luchner, G. A. Riegger, H.-W. Hense, et al. Relation of the G Protein {beta}3-Subunit Polymorphism With Left Ventricle Structure and Function Hypertension, August 1, 2002; 40(2): 162 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
J R Ortlepp, H P Vosberg, S Reith, F Ohme, N G Mahon, D Schroder, H G Klues, P Hanrath, and W J McKenna Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene Heart, March 1, 2002; 87(3): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Luchner, U. Brockel, M. Muscholl, H.-W. Hense, A. Doring, G. A.J Riegger, and H. Schunkert Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study Cardiovasc Res, February 15, 2002; 53(3): 720 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Delles, J. Erdmann, J. Jacobi, K. F. Hilgers, E. Fleck, V. Regitz-Zagrosek, and R. E. Schmieder Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension J. Am. Coll. Cardiol., March 1, 2001; 37(3): 878 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Lim, A. Hautanen, M. Manttari, M. Kupari, V. Manninen, P. Toivanen, L. Tenkanen, K. M. Kayes, S. Rosenfeld, and P. C. White Smoking and Aldosterone Synthase Polymorphism Response Circulation, December 12, 2000; 102 (24): e183 - e183. [Full Text] [PDF] |
||||
![]() |
N. Padmanabhan, S. Padmanabhan, and J. M. Connell Genetic basis of cardiovascular disease -- the renin-angiotensin-aldosterone system as a paradigm Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 316 - 324. [PDF] |
||||
![]() |
C. Hengstenberg, S. R. Holmer, B. Mayer, H. Lowel, S. Engel, H.-W. Hense, G. A. J. Riegger, and H. Schunkert Evaluation of the Aldosterone Synthase (CYP11B2) Gene Polymorphism in Patients With Myocardial Infarction Hypertension, March 1, 2000; 35(3): 704 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jamshidi, H. E. Montgomery, H.-W. Hense, S. G. Myerson, I. P. Torra, B. Staels, M. J. World, A. Doering, J. Erdmann, C. Hengstenberg, et al. Peroxisome Proliferator-Activated Receptor {alpha} Gene Regulates Left Ventricular Growth in Response to Exercise and Hypertension Circulation, February 26, 2002; 105(8): 950 - 955. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |